Sponsored content by EZ Newswire. The Fortune staff was not involved in producing this content.
National Nonprofits Advancing Fertility Access and Education Announce 2025 Fall IVF Grant Recipients
The Wyatt Fertility Foundation and the Conceive Fertility Foundation award five $15,000 IVF grants to aspiring parents facing the heartbreak of infertility
HOUSTON, TX
December 19, 2025, 11:07 AM ET
Source: Wyatt Foundation (EZ Newswire)
HOUSTON, TX, December 19, 2025 (EZ Newswire) -- The Wyatt Fertility Foundation and the Conceive Fertility Foundation, two national nonprofit organizations committed to expanding access, education, and research in fertility care, today announce the five recipients of their 2025 Fall IVF Grant Program.
Each recipient will receive a $15,000 IVF grant to help offset the cost of IVF treatment. In addition, recipients will receive $1,000 toward preimplantation genetic testing (PGT), generously provided by CooperSurgical, a long-standing leader in fertility and women’s health.
The national grant program first launched in 2024, and the fall campaign drew more than 450 applications from across the United States. Each story reflected the emotional, physical, and financial realities faced by individuals and couples navigating infertility. The recipients were selected following a comprehensive review process and represent diverse family-building journeys.
“While every applicant’s story was deeply personal, a common thread emerged — infertility often brings profound emotional strain alongside physical and financial challenges,” said Dr. Alice D. Domar, health psychologist, chief compassion officer at Inception Fertility, and director of the Inception Research Institute. “Programs like this help shine a light on the lived experience of infertility and reinforce the urgent need for greater access to compassionate, comprehensive fertility care.”
The five grant recipients include aspiring parents who have persevered through a wide range of challenges, including pregnancy and infant loss, failed IUI cycles, endometriosis, and male factor infertility. Despite these obstacles, each remains devoted to their hope of building a family.
The Wyatt Fertility Foundation is the nonprofit arm of Inception Fertility™, the largest provider of fertility services in North America. A 501(c)(3) organization, the foundation is dedicated to helping individuals and couples achieve their dreams of parenthood through assisted reproductive technology (ART). The organization was founded by Inception Fertility CEO TJ Farnsworth and his wife, Margaret Farnsworth, who welcomed their first child, Wyatt, through IVF.
“We are honored to support this program and the individuals whose resilience and determination inspire everything we do,” said Margaret Farnsworth, executive director of The Wyatt Fertility Foundation. “As the year comes to a close, we are proud to help provide meaningful support to these recipients as they continue their family-building journeys in 2026.”
The Conceive Fertility Foundation is the nonprofit arm of Caden Lane, a direct-to-consumer lifestyle brand centered around the birth of a child. A 501(c)(3) organization, the foundation supports individuals impacted by infertility through education, advocacy, and financial assistance. Caden Lane CEO Katy Mimari launched the foundation following her own experience with infertility and a desire to help reduce the financial barriers faced by so many hopeful parents. A portion of Caden Lane’s proceeds supports the foundation’s work.
“At Caden Lane, family is at the heart of everything we do,” said Katy Mimari, CEO of Caden Lane and The Conceive Fertility Foundation. “We are deeply grateful to partner once again with The Wyatt Fertility Foundation to help make parenthood possible for these recipients. As we head into the holiday season, we are honored to support their next steps and celebrate the hope ahead.”
About Wyatt Foundation
Wyatt Foundation is a 501(c)(3) nonprofit organization dedicated to helping individuals and couples achieve their dream of building a family through assisted reproductive technology (ART) by reducing the financial barriers to IVF through scholarships awarded based on financial need and clinical factors determining potential success. The foundation has two main goals: to provide financial assistance to individuals and couples who cannot afford fertility treatments and to fund research in the field of infertility.
The organization was started by TJ Farnsworth the founder and CEO of Inception Fertility™ and his wife Margaret who successfully conceived their first child through IVF. Upon the birth of their son Wyatt, TJ reflected back on his family's experience as patients. He realized that many aspiring parents were carrying the same emotional burden that he and his wife had — and that few fertility clinics took a holistic approach to consider the physical, psychological, financial and mental aspects of infertility.
Founded by Katy Mimari, CEO of Caden Lane, Conceive Fertility Foundation is a non-profit organization committed to supporting individuals affected by infertility through education and grants. Despite insurance covering diagnostics, treatment costs are a significant financial burden and Conceive Fertility is a non-profit organization that exists to help couples who are struggling to conceive. A portion of sales from Caden Lane go to support the mission of the Conceive Fertility Foundation.
Inception Fertility™ (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes.
Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership.
Through its growing family of national organizations — which includes The Prelude Network®, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations.
CooperSurgical is a leading fertility and women's healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most in life. CooperSurgical is at the forefront of delivering innovative assisted reproductive technology (ART) and genomic solutions that enhance the work of ART professionals to the benefit of families. We currently offer over 600 clinically relevant medical devices to women's healthcare providers, including testing and treatment options.
CooperSurgical is a wholly-owned subsidiary of CooperCompanies (NASDAQ: COO). CooperSurgical, headquartered in Trumbull, CT, produces and markets a wide array of products and services for use by women's healthcare clinicians.
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life's beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women's healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 16,000, sells products in over 130 countries, and positively impacts over 50 million lives each year.
